310 related articles for article (PubMed ID: 12773985)
1. Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions.
Berger DH; O'Mahony CA; Sheng H; Shao J; Albo D; DuBois RN; Beauchamp RD
Surgery; 2003 May; 133(5):568-79. PubMed ID: 12773985
[TBL] [Abstract][Full Text] [Related]
2. Transformation of intestinal epithelial cells by chronic TGF-beta1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2.
Sheng H; Shao J; O'Mahony CA; Lamps L; Albo D; Isakson PC; Berger DH; DuBois RN; Beauchamp RD
Oncogene; 1999 Jan; 18(4):855-67. PubMed ID: 10023661
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
Fujimoto K; Sheng H; Shao J; Beauchamp RD
Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 alters transforming growth factor-beta 1 response during intestinal tumorigenesis.
O'Mahony CA; Beauchamp RD; Albo D; Tsujii M; Sheng HM; Shao J; Dubois RN; Berger DH
Surgery; 1999 Aug; 126(2):364-70. PubMed ID: 10455907
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells.
Sheng H; Shao J; Hooton EB; Tsujii M; DuBois RN; Beauchamp RD
Cell Growth Differ; 1997 Apr; 8(4):463-70. PubMed ID: 9101092
[TBL] [Abstract][Full Text] [Related]
6. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Garcia M
J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
[TBL] [Abstract][Full Text] [Related]
8. The effect of thrombospondin-1 and TGF-beta 1 on pancreatic cancer cell invasion.
Albo D; Berger DH; Tuszynski GP
J Surg Res; 1998 Apr; 76(1):86-90. PubMed ID: 9695745
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells.
Hui AY; Dannenberg AJ; Sung JJ; Subbaramaiah K; Du B; Olinga P; Friedman SL
J Hepatol; 2004 Aug; 41(2):251-8. PubMed ID: 15288474
[TBL] [Abstract][Full Text] [Related]
10. A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells.
Liu H; Peng Y; Liu F; Li J; Chen X; Liu Y; Zhang H
Cell Biol Int; 2007 May; 31(5):508-15. PubMed ID: 17196403
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta inhibits Akt-induced transformation in intestinal epithelial cells.
Cao Y; Deng C; Townsend CM; Ko TC
Surgery; 2006 Aug; 140(2):322-9. PubMed ID: 16904986
[TBL] [Abstract][Full Text] [Related]
12. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
13. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
[TBL] [Abstract][Full Text] [Related]
14. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells.
Uttamsingh S; Bao X; Nguyen KT; Bhanot M; Gong J; Chan JL; Liu F; Chu TT; Wang LH
Oncogene; 2008 Apr; 27(18):2626-34. PubMed ID: 17982486
[TBL] [Abstract][Full Text] [Related]
16. Chronic exposure of transforming growth factor beta 1 confers a more aggressive tumor phenotype through downregulation of p21(WAF1/CIP1) in conditionally immortalized pancreatic epithelial cells.
Ito D; Fujimoto K; Doi R; Koizumi M; Toyoda E; Mori T; Kami K; Kawaguchi Y; Whitehead R; Imamura M
Surgery; 2004 Aug; 136(2):364-74. PubMed ID: 15300203
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.
Kim HP; Lee MS; Yu J; Park JA; Jong HS; Kim TY; Lee JW; Bang YJ
Biochem J; 2004 Apr; 379(Pt 1):141-50. PubMed ID: 14720123
[TBL] [Abstract][Full Text] [Related]
18. Modulation of ezrin and E-cadherin expression by IL-1beta and TGF-beta1 in human trophoblasts.
Karmakar S; Das C
J Reprod Immunol; 2004 Dec; 64(1-2):9-29. PubMed ID: 15596224
[TBL] [Abstract][Full Text] [Related]
19. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.
Santibáñez JF; Frontelo P; Iglesias M; Martínez J; Quintanilla M
J Cell Biochem; 1999 Jul; 74(1):61-73. PubMed ID: 10381262
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
